ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Eyenovia Inc

Eyenovia Inc (EYEN)

0.146
0.0327
(28.86%)
Closed January 01 4:00PM
0.152
0.006
(4.11%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.152
Bid
0.15
Ask
0.1545
Volume
412,826,191
0.135 Day's Range 0.2249
0.077 52 Week Range 2.57
Market Cap
Previous Close
0.1133
Open
0.2248
Last Trade Time
Financial Volume
$ 64,469,209
VWAP
0.156166
Average Volume (3m)
11,354,110
Shares Outstanding
86,441,611
Dividend Yield
-
PE Ratio
-0.48
Earnings Per Share (EPS)
-0.32
Revenue
4k
Net Profit
-27.26M

About Eyenovia Inc

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precis... Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Eyenovia Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEN. The last closing price for Eyenovia was $0.11. Over the last year, Eyenovia shares have traded in a share price range of $ 0.077 to $ 2.57.

Eyenovia currently has 86,441,611 shares outstanding. The market capitalization of Eyenovia is $9.79 million. Eyenovia has a price to earnings ratio (PE ratio) of -0.48.

EYEN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.066277.15617715620.08580.1520.0823220798930.10721605CS
40.060165.39717083790.09190.1520.077182085270.09595029CS
12-0.338-68.97959183670.490.59160.077113541100.11590266CS
26-0.4858-76.16807776730.63781.560.07761282510.20080051CS
52-1.938-92.72727272732.092.570.07736001710.32919819CS
156-3.688-96.04166666673.845.850.07713704770.60360624CS
260-3.808-96.16161616163.967.720.0779411581.14347489CS

EYEN - Frequently Asked Questions (FAQ)

What is the current Eyenovia share price?
The current share price of Eyenovia is $ 0.152
How many Eyenovia shares are in issue?
Eyenovia has 86,441,611 shares in issue
What is the market cap of Eyenovia?
The market capitalisation of Eyenovia is USD 9.79M
What is the 1 year trading range for Eyenovia share price?
Eyenovia has traded in the range of $ 0.077 to $ 2.57 during the past year
What is the PE ratio of Eyenovia?
The price to earnings ratio of Eyenovia is -0.48
What is the reporting currency for Eyenovia?
Eyenovia reports financial results in USD
What is the latest annual turnover for Eyenovia?
The latest annual turnover of Eyenovia is USD 4k
What is the latest annual profit for Eyenovia?
The latest annual profit of Eyenovia is USD -27.26M
What is the registered address of Eyenovia?
The registered address for Eyenovia is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Eyenovia website address?
The website address for Eyenovia is www.eyenoviabio.com
Which industry sector does Eyenovia operate in?
Eyenovia operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDMDBaird Medical Investment Holdings Ltd
$ 7.6699
(630.47%)
89.74M
APMAptorum Group Ltd
$ 2.799
(106.57%)
116.74M
COEPCoeptis Therapeutics Holdings Inc
$ 5.44
(75.48%)
5.08M
VRMEVerifyMe Inc
$ 1.332
(68.63%)
94.05M
VEEETwin Vee PowerCats Company
$ 0.55
(53.59%)
5.62M
WATTEnergous Corporation
$ 1.00
(-62.26%)
29.33M
SGMOSangamo Therapeutics Inc
$ 1.02
(-56.41%)
44.56M
INTZIntrusion Inc
$ 3.07
(-45.95%)
15.07M
KZIAKazia Therapeutics Ltd
$ 1.78
(-42.58%)
708.99k
TOIIWOncology Institute Inc
$ 0.0052
(-42.22%)
366.02k
SVMHSRIVARU Holding Ltd
$ 0.0423
(26.65%)
794.74M
XTIAXTI Aerospace Inc
$ 0.0422
(6.84%)
446.31M
EYENEyenovia Inc
$ 0.1474
(30.10%)
412.83M
CRKNCrown Electrokinetics Corporation
$ 0.146899
(5.91%)
402.05M
ONCOOnconetix Inc
$ 0.6479
(48.26%)
270.47M

EYEN Discussion

View Posts
glenn1919 glenn1919 2 days ago
eyen....................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783




onit...............
👍️0
tw0122 tw0122 2 days ago
.30 + 150%
👍️0
tw0122 tw0122 2 days ago
8k keep an eye here 
👍️0
hondaboost hondaboost 1 month ago
Scam: selling 24 Million new shares at $0.10 , just before probable "Bankruptcy"!

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchase and sale of 12,081,785 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 24,163,570 shares of common stock in a registered direct offering at a combined offering price of $0.1076 per share and accompanying warrants. T
👍️0
glenn1919 glenn1919 1 month ago
EYEN..............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
RC_702 RC_702 3 months ago
And then again, maybe not. You still up 200% or did you sell during that balloon ride
👍️0
saigai saigai 3 months ago
still holding.. see you at trips
👍️0
saigai saigai 3 months ago
just going to hold i dont care anymore im tired of wishing on a star..im better off spending my days with the prayer beads than this nonsense
👍️0
saigai saigai 4 months ago
eyen 3200 at .59 lets gooo
👍️0
rosemountbomber rosemountbomber 4 months ago
Have to agree with you. I was surprised at the size of this offering. Rather not go through this again so will lighten up or liquidate completely on the next strong upward move.
👍️0
ProLiberty ProLiberty 4 months ago
It cost the company a 40% decline and dilution at $0.40 in exchange for 2.5 months of added runway. Not long ago they raised another $5m from 2 investors at $0.62 + warrants (also dilutive). They hope Oct data will allow accelerated approval of Micropine but even if good and accelerated still 12 months from approval. They will still burn and need to raise multiple times between now and 12 months from now. Perhaps they will be able to do it at a higher stock price if the Oct data is good but unclear. To buy today you need to be very confident that Oct data will be excellent.
👍️0
Monksdream Monksdream 4 months ago
EYEN new 52 low
👍️0
govprs govprs 4 months ago
I added. Great buy the dip opportunity
👍️0
rosemountbomber rosemountbomber 4 months ago
Well the good thing arrived this morning. 13 million share dilution:

https://finance.yahoo.com/news/eyenovia-announces-pricing-5-14-132900005.html
👍️0
Southern Gal Southern Gal 5 months ago
Another good day. I'm up 93.15% in 2 months time.

Typically, when an insider loads up, good thing are coming.
👍️ 1
rosemountbomber rosemountbomber 5 months ago
Thanks. Info 20 days late
👍️ 1
glenn1919 glenn1919 5 months ago
EYEN............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
Southern Gal Southern Gal 5 months ago
INSIDER BUYS $660,000 WORTH OF EYEN
Name: GRANT STUART M
Symbol Date Shares Proceeds Transaction Details
EYEN 2024-07-02 1.515M $1,000,000.00 Purchase at $0.66 per share.

https://benchwalk.com/bench-walk-advisors-llc-litigation-financing-experts-team/stuart-grant-co-founder-managing-director
👍️0
Monksdream Monksdream 5 months ago
EYEN under $2
👍️0
Southern Gal Southern Gal 6 months ago
Wow!! Another BIG up day

$1.18

+$0.11
+10.28%
👍️0
Southern Gal Southern Gal 6 months ago
Well- I got my $1. Looking for more
👍️0
Southern Gal Southern Gal 7 months ago
Picked up more today.
Time will tell...
👍️0
Southern Gal Southern Gal 7 months ago
I started buying today. Looking for $1
👍️0
Dennis14 Dennis14 9 months ago
I bought in today. Now I’ll sit and wait.
👍️0
Monksdream Monksdream 9 months ago
EYEN new 52 lo
👍️0
Monksdream Monksdream 9 months ago
EYEN new 52 lo
👍️0
Monksdream Monksdream 10 months ago
EYEN under $2
👍️0
Monksdream Monksdream 10 months ago
EYEN under $2
👍️0
glenn1919 glenn1919 10 months ago
EYEN..........................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
EYEN.......................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
EYEN under $2
👍️0
Monksdream Monksdream 1 year ago
EYEN new 52 week low
👍️0
Monksdream Monksdream 1 year ago
EYEN new 52 week low
👍️0
Monksdream Monksdream 1 year ago
EYEN under $2
👍️0
honest dave honest dave 3 years ago
EYEN --
--Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating
BY MT Newswires
— 9:31 AM ET 10/26/2021
👍️0
jdlamont jdlamont 4 years ago
EYEN now trading options!!!!
👍️0
jdlamont jdlamont 4 years ago
EYEN now trading options!!!!
👍️0
beambe beambe 4 years ago
Good NEWS
👍️0
beambe beambe 4 years ago
good Volume
👍️0
beambe beambe 4 years ago
https://eyenovia.com/about-2019/

👍️0
ClayTrader ClayTrader 4 years ago
* * $EYEN Video Chart 08-11-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
beambe beambe 4 years ago
good Volume
👍️0
breezy1 breezy1 4 years ago
OCGN - .62 orphan FDA approvals
👍️0
crudeoil24 crudeoil24 4 years ago
Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea
8:05 am ET August 11, 2020 (Globe Newswire) Print
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs

Arctic Vision to Lead Expansion of Novel Approach to Treating Myopia and Presbyopia in Greater China and South Korea

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP(TM)) therapeutics and Arctic Vision, a clinical stage biotech company focused on developing and commercializing innovative ophthalmology therapies in China and Asia, today announced that they have entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Under the terms of the agreement, Eyenovia may receive up to a total of $45.75 million in upfront payments as well as additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. In addition, Arctic Vision will purchase its supply of MicroPine and MicroLine from Eyenovia or, for such products not supplied by Eyenovia, pay Eyenovia a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. Eyenovia will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to its Asian licensee pursuant to the arrangement
👍️0
BioSpecialist BioSpecialist 5 years ago
next $10 stock soon
👍️0
BioSpecialist BioSpecialist 5 years ago
STRONG BUY
👍️0
BioSpecialist BioSpecialist 5 years ago
EYEN = MC $60 Million /NDA submission for BIG drug in Q3 / 2 more Drugs in Phase 3 including a potential Blockbuster /Undiscovered low float gem = A Potential 10+ Bagger Gem ..GLTA



👍️0
jdlamont jdlamont 5 years ago
anyone who sees the video of the kid using the machine will buy the stock.
So easy and simple to use-REVOLUTIONARY. Very impressive.
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
looks like next breakout about to start
👍️0

Your Recent History

Delayed Upgrade Clock